David Feigal
Impact in
- Parasitology top 5%
- Toxoplasma gondii Research Studies
- Parasitic Infections and Diagnostics
- Virology top 10%
Papers in
-
- Pneumocystis jirovecii pneumonia detection and treatment 1
-
- Pharmaceutical industry and healthcare 2
- Co-authors
- Joseph Chiu (2 shared papers)Joseph Nussbaum (2 shared papers)J. Allen McCutchan (2 shared papers)John M. Leedom (2 shared papers)Angie E. Bartok (2 shared papers)Jean‐Louis Vildé (1 shared paper)Catherine Leport (1 shared paper)Nathan Clumeck (1 shared paper)
- Journals
- Annals of Internal Medicine (2 papers)Catheterization and Cardiovascular Interventions (1 paper)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
David Feigal
3 papers receiving 370 citations
Peers
Comparison fields: 5 of 59
- Parasitology 189
- Virology 44
- Epidemiology 291
- Infectious Diseases 120
- Microbiology 17
Countries citing papers authored by David Feigal
This map shows the geographic impact of David Feigal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Feigal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Feigal more than expected).
Fields of papers citing papers by David Feigal
This network shows the impact of papers produced by David Feigal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Feigal. The network helps show where David Feigal may publish in the future.
Co-authors
The 23 scholars most cited alongside David Feigal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 261 | |
| 2 | 1992 | 110 | |
| 3 | 2007 | 15 | |
| 4 | Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance. | 2007 | 0 |
About David Feigal
David Feigal is a scholar working on Epidemiology, Pharmacology, Infectious Diseases, Organic Chemistry and Pediatrics, Perinatology and Child Health, having authored 4 papers that have together received 386 indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), Pharmaceutical studies and practices (1 paper), Quinazolinone synthesis and applications (1 paper), Academic Publishing and Open Access (1 paper), Toxoplasma gondii Research Studies (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Pharmaceutical Economics and Policy (1 paper). The work is most often cited by research in Parasitology (189 citations), Virology (44 citations), Epidemiology (291 citations), Infectious Diseases (120 citations) and Microbiology (17 citations). David Feigal has collaborated with scholars based in United States. Frequent co-authors include Joseph Chiu, Joseph Nussbaum, J. Allen McCutchan, John M. Leedom, Angie E. Bartok, Jean‐Louis Vildé, Catherine Leport, Nathan Clumeck, Peter N.R. Heseltine and Brian Dannemann. Their work appears in journals such as Annals of Internal Medicine, Catheterization and Cardiovascular Interventions and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.